Companies
Data from Myriad Genetics offered early validation evidence for an expanded version of its commercial test, as well as a look into clinical impact via claims data.
T2 Biosystems Receives Delisting Notice From Nasdaq
The company has requested a hearing and paid a $20,000 fee to delay its delisting determination until Jan. 9, 2025.
In Brief This Week: Labcorp, Abbott, Danaher, MeMed, Co-Diagnostics, More
News items for the week of Dec. 9, 2024.
Roche Receives CE Mark for Updated High-Throughput Cobas Platform
The new Cobas 6800/8800 systems 2.0 enhances throughput and run flexibility and enables sample prioritization.
MedSanTek to Distribute Bio-Techne Products in Turkey
The company will distribute products from Bio-Techne's R&D Systems, Novus, Tocris, Protein Simple, Advanced Cell Diagnostics, and Asuragen brands.